|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
12
|
|
pubmed:dateCreated |
2009-5-27
|
|
pubmed:abstractText |
Transcatheter arterial chemoembolization (TACE) has been limited in palliative treatment of unresectable hepatocellular carcinoma (HCC) with major portal vein (PV) invasion due to the possibility of liver failure following embolization. Transcatheter arterial chemoinfusion (TACI) has been an option in such cases.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jun
|
|
pubmed:issn |
1365-2036
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:day |
15
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1291-8
|
|
pubmed:meshHeading |
pubmed-meshheading:19392861-Adult,
pubmed-meshheading:19392861-Aged,
pubmed-meshheading:19392861-Carcinoma, Hepatocellular,
pubmed-meshheading:19392861-Chemoembolization, Therapeutic,
pubmed-meshheading:19392861-Combined Modality Therapy,
pubmed-meshheading:19392861-Female,
pubmed-meshheading:19392861-Follow-Up Studies,
pubmed-meshheading:19392861-Humans,
pubmed-meshheading:19392861-Infusions, Intra-Arterial,
pubmed-meshheading:19392861-Liver Neoplasms,
pubmed-meshheading:19392861-Male,
pubmed-meshheading:19392861-Middle Aged,
pubmed-meshheading:19392861-Portal Vein,
pubmed-meshheading:19392861-Statistics as Topic,
pubmed-meshheading:19392861-Survival Analysis,
pubmed-meshheading:19392861-Treatment Outcome,
pubmed-meshheading:19392861-Venous Thrombosis
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Transcatheter arterial chemoembolization vs. chemoinfusion for unresectable hepatocellular carcinoma in patients with major portal vein thrombosis.
|
|
pubmed:affiliation |
Department of Radiology and Research Institute of Radiology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.
|
|
pubmed:publicationType |
Journal Article
|
